Jeremy Grantham Haleon PLC Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $31.8 Billion
- Q2 2025
A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Haleon PLC stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 785,238 shares of HLN stock, worth $7.33 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
785,238
Previous 454,182
72.89%
Holding current value
$7.33 Million
Previous $4.67 Million
74.23%
% of portfolio
0.03%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding HLN
# of Institutions
709Shares Held
468MCall Options Held
158KPut Options Held
0-
Dodge & Cox San Francisco, CA155MShares$1.45 Billion0.97% of portfolio
-
Clearbridge Investments, LLC New York, NY31.4MShares$293 Million0.28% of portfolio
-
Harding Loevner LP Bridgewater, NJ22.6MShares$210 Million1.62% of portfolio
-
Morgan Stanley New York, NY17.7MShares$165 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA16.7MShares$156 Million0.03% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $43.1B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...